Health Authorities To Test Experimental Ebola Vaccine In DRC Outbreak With 43 Suspected Cases

Financial Times: Congo to test experimental Ebola vaccine as disease re-emerges
“Health authorities in the Democratic Republic of Congo are preparing to use an experimental vaccine to help fight an outbreak of Ebola, in what could be an important step towards getting regulatory approval for the world’s first vaccine against the deadly virus. The World Health Organization said on Tuesday that there were 43 suspected cases of Ebola in the remote northern Bas Ulele province of Congo, with four deaths and two laboratory-confirmed cases. More confirmed cases were likely, it said…” (Pilling, 5/23).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.